Clinical characterization of Lassa fever: A systematic review of clinical reports and research to inform clinical trial design.
<h4>Background</h4>Research is urgently needed to reduce the morbidity and mortality of Lassa fever (LF), including clinical trials to test new therapies and to verify the efficacy and safety of the only current treatment recommendation, ribavirin, which has a weak clinical evidence base...
Guardado en:
Autores principales: | Laura Merson, Josephine Bourner, Sulaiman Jalloh, Astrid Erber, Alex Paddy Salam, Antoine Flahault, Piero L Olliaro |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/a9d74b30ed184195b7b4f569fd7ece53 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Time to reconsider the role of ribavirin in Lassa fever.
por: Alex Paddy Salam, et al.
Publicado: (2021) -
Successful Outpatient Management of Children at a Secondary Care Hospital in Pakistan in a Dengue Fever Epidemic and Their Clinical Outcomes
por: Ammara Farooq, et al.
Publicado: (2021) -
Health seeking behavior after the 2013-16 Ebola epidemic: Lassa fever as a metric of persistent changes in Kenema District, Sierra Leone.
por: Mikaela R Koch, et al.
Publicado: (2021) -
Prevalence of Helicobacter pylori among Patients with Gastrointestinal Tract (GIT) Symptoms: A Retrospective Study at Selected Africa Air Rescue (AAR) Clinics in Kampala, Uganda, from 2015 to 2019
por: Edity Namyalo, et al.
Publicado: (2021) -
Setting up a pragmatic clinical trial in a low-resource setting: A qualitative assessment of GoLBeT, a trial of podoconiosis management in Northern Ethiopia.
por: Astrid C Erber, et al.
Publicado: (2021)